Abstract
To evaluate the feasibility and clinical usefulness of immunocytochemical detection of bone marrow metastases in neuroblastoma, we studied bone marrow samples from patients undergoing intensive therapy, followed in the majority of cases by autologous bone marrow rescue. Two monoclonal antibodies were used in an indirect immunoenzymatic assay to test 384 samples collected from multiple bone marrow sites during 79 staging procedures in 48 patients. Of 578 immunocytochemical tests, 59 (10%) yielded non-evaluable results. Analysis by individual bone marrow sites showed an agreement between cytological and immunocytochemical examinations in 276 of 309 (89%) evaluable tests with 5 A7 and in 179 of 210 (85%) with UJ 13 A. Infiltration by neuroblastoma cells was reported in 9% of samples by cytology, in 6% by immunochemistry with 5 A7 and in 16% with 13 A. Analysis of results by staging demonstrated agreement between cytological examination and immunocytochemical detection with both monoclonal antibodies in 60 of 75 (80%) evaluable stagings. Bone marrow metastasis was detected by cytology in 22% of stagings, by immunochemistry with 5 A7 in 23%, with UJ 13 A in 25%. Detailed analysis of discordant results revealed that they were related partly to bone marrow sampling variability associated with focal and minimal metastasis of neuroblastoma cells. These data suggest the clinical usefulness of immunocytochemical detection as a complementary test to cytological examination for accurate evaluation of bone marrow infiltration in patients with disseminated neuroblastoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- IC:
-
immunocytochemical detection
- BM:
-
bone marrow
- Mabs:
-
monoclonal antibodies
- CE:
-
cytological examination
- NBL:
-
neuroblastoma
- staging:
-
staging procedure
References
Allan PM, Garson JA, Harper EI, Asser U, Coakham HB, Brownell B, Kemshead JT (1983) Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer 31:591–598
August CS, Serota FT, Koch PA, Burkey E, Schlesinger H, Elkins WL, Evans AE, D'Angio GJ (1984) Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation and allogeneic or autologous marrow reconstitution. J Clin Oncol 2:609–616
Bayle C, Allard T, Rodary C, Vanderplaucke J, Hartmann O, Lemerle J (1985) Detection of bone marrow involvement by neuroblastoma: comparison of two cytological methods. Eur Paediatr Haematol Oncol 2:123–128
Bostrom B, Nesbit ME, Brunning RD (1985) The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastoma. Am J Pediatr Hematol Oncol 7:303–305
Brodeur JM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastoma correlates with advanced disease stage. Science 224:1121–1124
Coldman AJ, Fryer CJ, Elwood JM, Sonley MJ (1980) Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis. Cancer 46:1896–1901
Evans AE, Hummeler K (1973) The significance of primitive cells in marrow aspirates of children with neuroblastoma. Cancer 82:906–912
Evans AE, Griffin GC, Tartaglione M, Kennett RH (1985) A method of detecting neuroblastoma in human bone marrow by means of two monoclonal antibodies PI 153/J and KE 2. Hybridoma 4:289–296
Favrot MC, Frappaz D, Maritaz O, Philip T, Fontanière B, Gentilhomme O, Bailly C, Zucker JM, Gentet JC, Kemshead J, Philip T (1986) Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow. Br J Cancer 54:637–641
Girardet C, Ladisch S, Heumann D (1983) Identification by a monoclonal antibody of a glycolipid highly expressed by cells from the human myeloid lineage. Int J Cancer 32:177–183
Gross N, Beck D, Carrel S, Munoz M (1986) Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplamic antigen. Cancer Res 46:2988–2994
Gross N, Beck D, Favre S, Carrel S (1987) In vitro antigenic modulation of human neuroblastoma cells induced by IFN-gamma, retinoic acid and dibutyryl cyclic AMP. Int J Cancer 39:521–529
Kemshead JT, Goldman A, Fritschy J, Malpas JS, Pritchard J (1983) Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders. Lancet I:12–15
Philip T, Biron P, Philip I, Favrot M, Bernard JL, Zucker JM, Lutz B, Plouvier E, Rebattu P, Carton M, Chauvot P, Dutou L, Souiller G, Philippe N, Bordigoni P, Lacroze M, Clapisson G, Olive D, Treleaven J, Kemshead JT, Brunat-Mentigny M (1985) Autologous bone marrow transplantation for very bad prognosis neuroblastoma. In: Evans EA, D'Angio GJ, Seeger RC (eds) Advances in neuroblastoma research. Liss, New York, p 569–586
Reynolds PC, Moss TJ, Seeger RC, Black AT, Woody JN (1985) Sensitive detection of neuroblastoma cells in bone marrow for monitoring the efficacy of marrow purging procedures. In: Evans EA, D'Angio GJ, Seeger RC (eds) Advances in neuroblastoma research. Liss, New York, p 425–441
Warnke RA, Gatter KC, Falini B, Hildreth P, Woolston RE, Pulford K, Cordell JL, Cohen B, De Wolf-Peeters C, Mason D (1983) Diagnosis of human lymphoma with monoclonal antibodies. N Engl J Med 309:1275–1281
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beck, D., Maritaz, O., Gross, N. et al. Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples. Eur J Pediatr 147, 609–612 (1988). https://doi.org/10.1007/BF00442474
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442474